|
|
Post by nylefty on Aug 11, 2020 15:51:40 GMT -5
Interesting that he says there are currently 3,000 script-writers for Afrezza. His goal is to get that to 4,000, each writing five scripts a week. Doing the math on that would mean that the current 3,000 are averaging less than one prescription per month (750 per week). I found it at least mildly interesting that their sales goal is less about getting new endos, and more about getting endos who currently have someone on Afrezza to put more patients on it. I don't think he said that there are "currently" 3,000 prescribers. What I took from it was that 3,000 docs (and other medical professionals) have prescribed Afrezza at one time or another, but that most have given up on it because they didn't know how to dose properly. |
|
|
|
Post by neil36 on Aug 11, 2020 16:03:55 GMT -5
NYLefty,
I agree. I think there are only a small number of endos who are doing most of the prescribing. He also spent a fair amount of time saying what we all know, which is that a lot of patients and doctors give up quickly over frustrations with getting the dosing right.
Neil
|
|
|
|
Post by sportsrancho on Aug 11, 2020 18:05:18 GMT -5
Oh my goodness, just come talk to Vdex!
|
|
|
|
Post by akemp3000 on Aug 11, 2020 19:25:29 GMT -5
Seriously? Spinning the take away from Mike's statements as negative and "most have given up on it..." is so dishonest and corrupt! Keep it up. The future is going to be fun  |
|
|
|
Post by cretin11 on Aug 11, 2020 19:29:27 GMT -5
Seriously? Spinning the take away from Mike's statements as negative and "most have given up on it..." is so dishonest and corrupt! Keep it up. The future is going to be fun Don’t the script numbers actually tell that tale? Not sure any “spinning” is needed. Get VDEX in the mix and retention will improve. Those doctors know how to properly instruct patients on using Afrezza, which will lead to more repeat customers. |
|
|
|
Post by cedafuntennis on Aug 11, 2020 20:33:36 GMT -5
Yes, I cannot understand for the life of me why the reticence to work closely with VDEX. It would be such a win-win-win. Win for MNKD, Win for VDEX and Win for the Patients. Maybe Mike would care to comment to us the shareholders as of his reasoning for this. With the many millions the company wasted on so many failed strategies, we could have been so far ahead. For example, instead of sponsoring that race car driver for a few weeks, those hundreds of thousands could have been so much smarter spent in this. And so many more. The TV stupid ads come to mind. Ads that were created by 2nd grade kids for beacoup bucks and the air time for millions that was wasted. Shall I go on?
|
|
|
|
Post by nylefty on Aug 11, 2020 21:14:19 GMT -5
Seriously? Spinning the take away from Mike's statements as negative and "most have given up on it..." is so dishonest and corrupt! Keep it up. The future is going to be fun Huh? My takeaway was not at all negative. I said Mike did a good job in his presentation and he's been very candid about the fact that many providers stopped prescribing Afrezza because they didn't know how to dose properly and therefore were getting disappointing results. Mike says that MannKind is working to fix that. So pointing that out is "dishonest and corrupt?" Paranoid much? |
|
|
|
Post by sportsrancho on Aug 11, 2020 21:26:45 GMT -5
Lefty and Neil are the last people that would spin anything.
Do you ever notice that the people that do not have any trouble at all dosing are the kids whose parents are Mannkind longs. Or Mannkind longs themselves:-)
|
|
|
|
Post by tarheelblue004 on Aug 12, 2020 7:46:19 GMT -5
Sports, I like where you’re going with this. Buy an Afrezza script, get 100 MNKD shares for free! ☺️
|
|
|
|
Post by agedhippie on Aug 12, 2020 7:55:17 GMT -5
There was also the claim that there was $25M untapped with MidCap which is rather disingenuous. That loan is dependent on hitting trailing 12 month revenue numbers and that is not happening so that money is not available. Yes MidCap may lend another $25M, or another lender may put up that money (unlikely since MidCap holds all the collateral), but the question is what concessions will they extract for that? We saw how this played out with Deerfield.
|
|
|
|
Post by slugworth008 on Aug 12, 2020 8:01:54 GMT -5
Oh my goodness, just come talk to Vdex! Yep - it's not that hard....and provide a dosing worksheet to endos and PCP's...what a concept. |
|
|
|
Post by sportsrancho on Aug 12, 2020 10:31:19 GMT -5
I was talking with Bill last night about the PWD on the Afrezza FB page. They seem to be thinking it stops working for various reasons.
Bill said, “ All that is wrong. Bad results = under dosing.”
( “My pt thus morning dropped from 14 to 7.2 on afrezza ofcourse. He is on 1/2 the Mets he was on before Afrezza.”)
“This is from one of our Diabetes Specialists. It is impossible to reduce A1c 7 points with anything other than Afrezza. Too bad other providers don’t know.
Every doc who tries Afrezza, doesn’t get the results and discontinues is lost perhaps forever. Since sales force accelerates that process it hurts the company. If one uses Afrezza and gets outstanding results they’re sold — as u can see in the quote I sent from our provider. Even if the company made no money on the script for the patient she refers to, SHES SOLD ON IT AND WILL WRITE MORE. That’s the key. Get great results even if with free scripts and you’ll get more use and people will pay.”
So going back to the problem this is caused by underdosing but the doctors are afraid of it. It’s just what u learn when you’re deeply involved in the actual prescription of the drug as Vdex is every day.
|
|
bkdmd
Researcher
Posts: 79
|
Post by bkdmd on Aug 12, 2020 10:40:32 GMT -5
The company is hurting itself. There is a lack of leadership and lack of being prepared and lack of being held accountable starting at the top of this company.
|
|
|
|
Post by agedhippie on Aug 12, 2020 11:21:01 GMT -5
I was talking with Bill last night about the PWD on the Afrezza FB page. They seem to be thinking it stops working for various reasons. Bill said, “ All that is wrong. Bad results = under dosing.” ( “My pt thus morning dropped from 14 to 7.2 on afrezza ofcourse. He is on 1/2 the Mets he was on before Afrezza.”) “This is from one of our Diabetes Specialists. It is impossible to reduce A1c 7 points with anything other than Afrezza. Too bad other providers don’t know. ... That really depends. At diagnosis it is doable because simply using insulin rather than nothing at all has a huge impact, later it is far harder because you have already got the low hanging fruit (so to speak). |
|
|
|
Post by sayhey24 on Aug 12, 2020 11:45:15 GMT -5
I was talking with Bill last night about the PWD on the Afrezza FB page. They seem to be thinking it stops working for various reasons. Bill said, “ All that is wrong. Bad results = under dosing.” ( “My pt thus morning dropped from 14 to 7.2 on afrezza ofcourse. He is on 1/2 the Mets he was on before Afrezza.”) “This is from one of our Diabetes Specialists. It is impossible to reduce A1c 7 points with anything other than Afrezza. Too bad other providers don’t know. ... That really depends. At diagnosis it is doable because simply using insulin rather than nothing at all has a huge impact, later it is far harder because you have already got the low hanging fruit (so to speak). Aged - the average A1c reduction for SGLT2 users is less than 1 and for GLP 1 users less than 2. The reality is only one thing can "really" reduce sugar in the blood and that is insulin. Once again, I have to agree with Bill. If the amount of insulin in their blood is not dropping the sugar, they need more insulin. Thats what the pancreas does and that is what the PWD using afrezza needs to do. How about the lady who is pregnant taking about 30 puffs a day including 1 and 2 unit doses to keep at her target. I am sure hoping Galindo is hatching a plan to offer all afrezza users connected care with something like Sugar IQ even if its only a free 3 month CGM/connected service trial. |
|
